PharmiWeb.com - Global Pharma News & Resources

Healthcare - Events

28-May-2024 - 29-May-2024
The Global Clinical Trials Connect 2024 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This multidisciplinary program involves broad participation of people from the clinical trials community from around the globe who are focused on learning more about clinical research, clinical trials planning and management. The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. It is high time that we look into innovative strategies, new technologies, effective and quality collab…
Global Clinical Trials Connect 2024
The last 3 years continue to see California rising as a competing biotech hub, incubating fast-growing biopharma and becoming a favored satellite site to large pharma in the West Coast. Notable developments include Moderna leasing a new campus in Seattle, Fred Hutchinson Cancer Center opened a $320m campus, and Gilead's new research center underway. However, lingering market volatility simply means lab operations managers within fast-growing biopharma in the West Coast need to be even more adept at business operations, as they play the critical role to the health of R and D pipeline progression and business continuity in 2024. As part of the flagship LAFM community, the premier Lab Operations and Facility Management for Biopharma Summit is here to provide the much-needed support for lab op…
Lab Ops and Facility Management for Biopharma Summit
The marcus evans 25th Edition Strategic Project & Portfolio Management for Pharma conference taking place on 3-5 June, 2024 in Barcelona, Spain, will provide a unique opportunity for leading project and portfolio experts to advance their critical decision-making capabilities and further maximise the value of their portfolio from early to late-stage developments. The conference is recognised by senior project & portfolio experts to be one of the most engaging and interactive events for the Pharma industry, bringing both actionable insights through concrete case studies and panels and maximising value of the meeting with unique discussion between expert speakers and attendees. Attending This Premier marcus evans Conference Will Enable You to: Level Up Your Strategic Portfolio Decisi…
25th edition Strategic Project & Portfolio Management for Pharma
In an era marked by remarkable advancements, the inhalation therapy field is rapidly evolving. From Avalyn's $175 million investment in inhaled pulmonary fibrosis trials to Krystal Biotech's FDA clearance for inhaled gene therapy and MIT engineers' work on inhaled nanoparticles, the field is abuzz with new advances and breakthroughs in inhalation delivery. Right now, we explore inhaled therapies as an opportunity to re-purpose modalities to tackle unmet clinical need in diseases like COPD, asthma, IPF, emphysema, and lung cancer, to unlock therapeutic efficacy. Now is the time for the industry to unite and innovate solutions to challenges surrounding particle engineering, stability, and formulation-device compatibility. Immerse yourself in a wealth of knowledge at the 2nd Next Gen Inhalati…
2nd Next Gen Inhalation Delivery Summit
2024 has just started and Cognito Therapeutics has reached a clinical milestone with their neuromod device, Medtronic’s closed loop SCS has successfully reduced overstimulation and SPR Therapeutics’ SPRINT PNS demonstrated efficacy! As leading device developers optimize their strategies and start-ups continue to grow, this explosive field is witnessing greater recognition and the potential to redefine the possibilities of bioelectric medicine to be used as a routine therapy is here. Coming to you in Boston, the Bioelectric Medicine Development Summit is the only industry forum dedicated to uniting likeminded experts to: -Cultivate this rapidly growing field by overcoming the competition and leveraging different perspectives into advancing DBS, VNS, BCI, SCS and more -Convince key stakehold…
Bioelectric Medicine Development Summit
SAE Media Group's 8th Annual Pre-Filled Syringes West Coast Conference will be back for 2024 in the West Coast to bring together device developers, biotech and big pharma. This year's conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation. As part of SAE's leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2024! What will you gain?- Engage in discussions on evolving EU and US regulations as well as reviewing the lat…
Pre-Filled Syringes West Coast Conference 2024
10-Jun-2024 - 12-Jun-2024
With 2024 set to be a pivotal year for TA teams in the Life Science space across Europe, we are excited to bring our longstanding LEAP TA: Life Science to Europe this year! This June, join us in London for the only Life Science focused talent acquisition summit, designed to spotlight the innovation enabling biopharma in Europe to meet their talent priorities in 2024 and beyond. The life sciences industry is facing unprecedented change. Disruptions from digitisation to a looming patent cliff are transforming the Life Science landscape, leading to a revolution in the roles and skills needed in 2024 and beyond. With such change, industry skills gaps are increasingly bringing challenges with skill mismatches, and recruiting experienced staff. To solve these challenges, Life Science companies m…
LEAP TA: Life Sciences Europe
The landscape of innate immune cells is rapidly advancing towards clinical applications. Multiple published studies in the last year repeatedly affirm that targeting myeloid cells rather than the cancer cells themselves can shrink tumors, further providing confidence in their potential as a clinically effective therapeutic. The 4th Annual Tumor Myeloid Targeting Therapies Summit captures this progressive momentum and is welcoming innate immunity experts frombiopharma and academia to showcase novel clinical practices across multiple myeloid subsets.As the field extends beyond macrophages, this meeting will also cover MDSCs, neutrophils and dendritic cells and delves into their intricate interactions within the TME for treating resistance in a range of cancers. Hear from the likes of MD Ande…
4th Tumor Myeloid Targeting Therapies Summit 2024
You are invited to ESPNIC X 2024, the Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care, in Rome, Italy, 11-14 June. The ESPNIC Meeting will unite PICU and NICU teams to foster collaboration and knowledge exchange among pediatric and neonatal intensive care healthcare professionals. The meeting promises to blend cutting-edge science presented by the community along with practical clinical care. Expect a dynamic and engaging atmosphere as you come together with international experts to explore the latest advancements, exchange insights, and chart the course for the future of pediatric and neonatal intensive care. Plus, take advantage of our ESPNIC SIM lab and attend ESPNIC Masterclasses to enhance and strengthen your practical skills. The ESPNIC Xperience is n…
ESPNIC 2024: Annual Meeting of the European Society of Paediatric and Neonatal Intensive Care
With the flux of investments and innovative technologies within the Plant Molecular Farming field starting to bloom, including the likes of Moolec Science, Miruku and BioBetter progressing their farming efforts, now is a critical window in which molecular farming pioneers must take advantage of innovative expression platforms and downstream technologies to overperform with yields, taste, texture, and nutrient profiles. Collating these established players alongside 60+ senior industry pioneers, the Plant Molecular Farming for Alternative Proteins and Agbio Summit is the first and only industry-led summit dedicated to molecular farming, uniting all relevant stakeholders across agbiotech, ingredient suppliers, big seed, and academia. Join C-level pioneers, innovation leads, product developmen…
Plant Molecular Farming for Alternative Proteins and Agbio Summit
11th Edition Human Factors and User Experience for Medical Device Design Conference Set to Equip Industry Leaders with Innovative Strategies Chicago, IL – 03/26/2024 - The highly anticipated 11th Edition Human Factors and User Experience for Medical Device Design Conference is scheduled to take place in Chicago, IL, from June 12 to June 13, 2024. Organized by marcus evans, this conference promises to provide attendees with invaluable insights into designing for testing, regulatory compliance, and optimal user and patient outcomes in the medical device industry. This conference is a must-attend event for professionals looking to gain a competitive advantage in enhancing end-user satisfaction, adopting novel testing methodologies, and implementing innovative designs for medical devices. Atte…
Redefine Tomorrow's ESG Standards Today to Drive Industry-Wide Progression Unprecedented, pivotal changes in the global ESG and sustainability regulatory landscape in Europe have landed business leaders under immense pressure to make their life sciences organisation a more environment-friendly and socially conscious business at its core. Therefore, now is the time to join us at the world's first and only forum dedicated to tackling the strategic ESG and sustainability challenges encountered by life sciences organisations of all stages and sizes in Europe. The ESG in Life Sciences Summit Europe 2024 will unite 60+ life sciences ESG, sustainability, CSR, EHS, legal, and finance leaders in Europe, as well as other key stakeholders (such as governing bodies, regulators, investors, and healthca…
54383 - ESG in Life Sciences Summit Europe
Engineering Safety and Developability for Complex Antibody-Based Therapeutics. The Antibody and Fusion Protein Engineering and Developability Summit returns as the protein developers' playbook on selecting and engineering the billion-dollar candidate, that can pair the right biology with a smooth progression through development. Uniting 80+ protein and antibody discovery leads, development scientists and antibody engineers, the Summit will equip you to take the guess work out of fusion and antibody-derived protein drug development, reducing drug development cost and time which has never been so important than in today's funding environment. URLs:Tickets: https://go.evvnt.com/2291577-2?pid=185Brochure: https://go.evvnt.com/2291577-3?pid=185 Time: 8:00 AM - 6:00 PM Speakers: Abhinav Gupta, S…
2nd Antibody and Fusion Protein Engineering and Developability Summit
18-Jun-2024 - 20-Jun-2024
Welcome to the 5th RNA Editing SummitPioneering RNA Editing Drugs Towards Clinical RealitiesDespite remarkable advancements, such as Wave Life Sciences pioneering the first clinical candidate and significant investments like Ascidian Therapeutics securing $40 million for their RNA editing pipeline, challenges persist in optimizing delivery and ensuring treatment longevity for new RNA editing therapies. Scheduled for June 2024, the 5th RNA Editing Summit is set to address these obstacles head-on. Our updated agenda features fresh content and an enhanced pre-conference focus day, spotlighting innovative platforms and strategies for targeting beyond the liver. Explore the latest breakthroughs in ADAR editing, RNA trans-splicing, gRNA-free editing, and RADAR technology. Join leading companies…
5th RNA Editing Summit
The innate immune system is increasingly being recognised as a target for a range of exciting applications with high unmet need, from those difficult to treat cancers to infectious and inflammatory disease. The past year has seen a mix of ups and downs for this space, with several companies entering the clinic, emerging new modalities of STING/TLR agonists and on the other side some clinical setbacks. The 5th Annual STING and TLR Targeted Therapies Summit returns at a crucial time to unpick the lessons of the past year and finally unleash the well-recognised potential of innate immunotherapy. In this dynamic field which continuously sees new approaches, keep track of all the goings on within industry, learn the best approach for selecting the right patient population and how to strike that…
5th STING And TLR-Targeted Therapies Summit 2024
19-Jun-2024 - 21-Jun-2024
This year the symposium is taking place in the Trinity Business School, Trinity College Dublin from the 19-21 June 2024.The programme will consist of research and clinical paper presentations, workshops, posters and a daily panel of speakers who are experts working in the field of seating and wheeled mobility. An innovative exhibition will showcase world leaders in powered and manual wheelchairs as well as seating and positioning systems. Date and Time: On Wed, 19 Jun 2024 09:00 - Fri, 21 Jun 2024 17:00
European Seating Symposium 2024
Join us at the 9th Edition of the International Conference on Neurology and Neurological Disorders (Neurology 2024) from June 20-22, 2024 in Paris, France and online. Neuromuscular Disorders Conference will cover the latest advancements in all aspects of neurology, with a focus on “BRAIN: Breeding Recent Advances in Neurology.” Hear from respected presenters and explore new approaches to improve care for neurological disorders. Register now to participate and stay up-to-date with Leading Neurologists at Neuropsychiatry Conference. Detailed information: Conference: 9th Edition of International Conference on Neurology and Neurological Disorders (Neurology 2024)Dates: June 20-22, 2024Venue: Paris, France and OnlineContact Email: neuro@magnusconference.com Phone: +1 (702) 988 2320WhatsApp: +1…
9th Edition of International Conference on Neurology and Neurological Disorders
Welcome to the International Cancer Research and Drug Discovery Conference (i-Cancer Congress), in London on March 22, 2024. We're excited to bring together healthcare professionals from around the world to discuss the latest developments and innovations. i-Cancer Congress is designed to provide a platform for experts in the field of oncology to share their knowledge, exchange ideas, and collaborate on new research projects. The conference will cover a wide range of topics related to cancer research, diagnosis, treatment, and prevention. With a range of presentations, workshops, and networking opportunities, attendees will have the chance to learn from some of the most accomplished healthcare professionals in the world. In addition to learning from expert speakers, attendees will also have…
International Cancer Research and Drug Discovery Conference (i-Cancer Congress)
24-Jun-2024 - 25-Jun-2024
Description : After the grand success of third year of nursing conference, we solicit your gracious presence at the “4th Edition - Nursing World Congress" (Nursing World 2024) which will be conducted during June 24-25, 2024 as a hybrid event at Rome, Italy and virtually. This conference will provide fresh perspectives, ideas, methods, and techniques, while no other conference will provide an exceptional mix of keynote speakers, excellent participants, and intriguing content. The many theme sessions will be discussed at this conference, and we invite everyone to attend. The Nursing World 2024 is a forum for Scientists, Engineers and Researchers to discuss and exchange Novel Ideas, Results, Experiences, and Work-in-process. This conference will also provide…
Nursing World Congress
From Process Safety to Rapid Scale-Up to Tech Transfer: Integrating Process Development, Industrial Hygiene and Equipment Selection to Achieve GMP Manufacturing of Novel High Potent Drug Compounds 2023 has been a pivotal year for novel high potent compounds securing early success and approvals – from Henlius’s ADC to Gilead’s Trodelvy to BMS’s Augtyro, cementing the growth of highly potent drugs market to reach USD$40.7bn by 2023. The rise in novel, more potent compounds, alongside EU Annex 1, are mounting pressure on biopharma, CDMOs and equipment providers to evolve their industrial hygiene, process engineering and manufacturing capabilities to ensure safe handling and effective scale-up to achieve commercial GMP manufacturing. The 13th HPAPI: Process Development for Highly Potent Drugs…
13th Process Development for Highly Potent Drugs Summit (HPAPI)